Cultural Adaptation and Piloting of a Smoking Cessation Intervention for Smokers With HIV



Status:Active, not recruiting
Conditions:Smoking Cessation, HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 90
Updated:10/4/2018
Start Date:April 4, 2018
End Date:June 30, 2019

Use our guide to learn which trials are right for you!

Cultural Adaptation and Piloting of an Avatar Delivered Smoking Cessation Intervention for Low Income Smokers in Baltimore City Living With HIV

One population of tobacco users that is severely affected by the consequences of smoking is
people living with HIV (PLWH). Between 40-84% of PLWH smoke, a percentage that has remained
constant since the first studies of smoking in HIV were conducted in the 1990's. Overall,
smoking related morbidity and mortality is also greatly increased among PLWH smokers.
Compared with PLWH nonsmokers, PLWH who smoke have more than 5 times the risk of
non-HIV-related mortality and almost 4 times the risk of all-cause mortality. Compared with
the general population, incidence ratio of smoking related cancers (eg, lung, head, neck,
bladder and esophageal) is more than 5 times higher. At a critical time when advances in HIV
care are providing an opportunity for prolonged life, smoking is significantly impeding the
health of PLWH.

To produce meaningful changes in smoking, however, treatment will have to be acceptable and
engaging to this population as well as feasible and sustainable to implement in a busy
clinic. Novel technology-based interventions that incorporate evidence-based behavioral and
pharmacologic interventions for smoking and are culturally tailored offer real solutions to
these implementation barriers. Research shows that internet- or computer-delivered
interventions (CDI) that are tailored and interactive can be efficacious in reducing smoking
and are significantly more effective than usual care or written self-help materials. CDIs can
also be readily adapted to different sociodemographic characteristics of a patient population
because content is modular and menu driven. Moreover, technology-based interventions appear
as effective as counselor-delivered interventions in reducing smoking. This growing body of
evidence strongly suggests that these interventions offer promise in reducing smoking, the
potential to reach significantly more patients, and the ability to overcome barriers of cost,
implementation, and cultural nonspecificity. The goal of this pilot study is test to examine
feasibility, acceptability of a computer-delivered smoking cessation intervention for PLWH,
and to determine if intervention participation results in increased readiness to quit smoking
and increased confidence in ability to quit smoking.

One population of tobacco users that is severely affected by the consequences of smoking is
people living with HIV (PLWH). Between 40-84% of PLWH smoke, a percentage that has remained
constant since the first studies of smoking in HIV were conducted in the 1990's. Overall,
smoking related morbidity and mortality is also greatly increased among PLWH smokers.
Compared with PLWH nonsmokers, PLWH who smoke have more than 5 times the risk of
non-HIV-related mortality and almost 4 times the risk of all-cause mortality. Compared with
the general population, their incidence ratio of smoking related cancers (eg, lung, head,
neck, bladder and esophageal) is more than 5 times higher. At a critical time when advances
in HIV care are providing an opportunity for prolonged life, smoking is significantly
impeding the health of PLWH.

To produce meaningful changes in smoking, however, treatment will have to be acceptable and
engaging to this population as well as feasible and sustainable to implement in a busy
clinic. Novel technology-based interventions that incorporate evidence-based behavioral and
pharmacologic interventions for smoking and are culturally tailored offer real solutions to
these implementation barriers. Research shows that internet- or computer-delivered
interventions (CDI) that are tailored and interactive can be efficacious in reducing smoking
and are significantly more effective than usual care or written self-help materials. CDIs can
also be readily adapted to different sociodemographic characteristics of a patient population
because content is modular and menu driven. Moreover, technology-based interventions appear
as effective as counselor-delivered interventions in reducing smoking. This growing body of
evidence strongly suggests that these interventions offer promise in reducing smoking, the
potential to reach significantly more patients, and the ability to overcome barriers of cost,
implementation, and cultural nonspecificity. The goal of this pilot randomized controlled
trial (RCT) is study is test to examine feasibility, acceptability of a computer-delivered
smoking cessation intervention for PLWH, and to determine if intervention participation
results in increased readiness to quit smoking and increased confidence in ability to quit
smoking.To pilot test the computer-delivered intervention among 40 individuals with HIV
receiving care in an urban HIV clinic in a small Randomized Controlled Trial 2a) To determine
intervention effect on 1) readiness to quit smoking 2) increased confidence in ability to
quit smoking 2) uptake of smoking cessation therapy, including a. Quit Line, b. Nicotine
replacement therapy c. Pharmacotherapy (varenicline, Wellbutrin) Hypothesis: Investigators
hypothesize that intervention participation will be associated with 1) increased readiness to
quit and confidence in quitting smoking and 2) increased engagement with smoking cessation
services.

2b) To examine feasibility and acceptability of delivering the computer-delivered smoking
cessation counseling in this setting.

Inclusion Criteria:

- Age >=18

- A patient in the Johns Hopkins University (JHU) Bartlett Clinic

- Smoked >100 cigarettes in their lifetime

- Current daily smoker (verified by exhaled carbon monoxide)

- English speaking.

Exclusion Criteria:

- Individuals will be excluded if they do not meet the above requirements
We found this trial at
1
site
3400 N Charles St
Baltimore, Maryland 21205
410-516-8000
Phone: 443-287-9858
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials